Rong Ma

Rong Ma


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in European Journal of Radiology
Verified
Journal Article
Closed access
YWYongMei Wang
YongMei Wang
WFWei Fan
Wei Fan
SZSong Zhao
Song Zhao
KZKai Zhang
Kai Zhang
LZLi Zhang
Li Zhang
RMRong Ma
Rong Ma

20 December 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YWYa-Wen Wang
Ya-Wen Wang
KZKai Zhang
Kai Zhang
SZSong Zhao
Song Zhao
YLYanrong Lv
Yanrong Lv
JZJiang Zhu
Jiang Zhu
JWJianli Wang
Jianli Wang
Despite recent evidence, the role of human papillomavirus (HPV) in breast carcinogenesis is controversial. The correlations of HPV infection with the clinicopathological features of breast cancer and the expression of cell cycle/apoptosis-associated proteins have not been well elucidated. In this study, we sought to determine the prevalence of high-risk HPVs (HR-HPVs) infection and BCL2, p21, p53, Rb, and survivin expression in breast cancer patients and to investigate the relationship of HPV with these cancer-related proteins, in an attempt to clarify the potential mechanism of HPV in breast cancer pathogenesis. HPV presence in 81 fresh breast cancer tissues was determined by hybrid capture 2 (HC2) assay, and expression of BCL2, p21, p53, Rb, and survivin was detected by immunohistochemistry. Here we showed that fourteen (17.3%) patients were HR-HPV positive. HPV infection demonstrated no significant correlation with the clinicopathological characteristics of breast cancer. HPV-positive tumors showed significantly higher BCL2 and lower p53 expression than HPV-negative tumors. Expression of p21, Rb, and survivin was not associated with HPV status. Our results suggest a possible role of HR-HPV in breast cancer carcinogenesis, in which BCL2 and p53 may be involved.

1 June 2021 in Pathology - Research and Practice
Verified
Journal Article
Closed access
KZKai Zhang
Kai Zhang
YWYan-Yan Wang
Yan-Yan Wang
YXYao Xu
Yao Xu
LZLi Zhang
Li Zhang
JZJiang Zhu
Jiang Zhu
RMRong Ma
Rong Ma

15 May 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
KZKai Zhang
Kai Zhang
SZSong Zhao
Song Zhao
QWQing Wang
Qing Wang
HYHsin-Sheng Yang
Hsin-Sheng Yang
JZJiang Zhu
Jiang Zhu
RMRong Ma
Rong Ma

22 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YMYu Mei
Yu Mei
SZSong Zhao
Song Zhao
XLXiaofei Lu
Xiaofei Lu
HLHaixia Liu
Haixia Liu
XLXiangyi Li
Xiangyi Li
RMRong Ma
Rong Ma
Elevated plasma fibrinogen levels are associated with tumor progression and poor outcomes in different cancer patients. The objective of this study was to investigate the clinical and prognostic value of preoperative plasma fibrinogen levels in patients with operable breast cancer. Two hundred and twenty-three patients diagnosed with breast cancer were retrospectively evaluated in this study. Plasma fibrinogen levels were examined before treatment and analyzed along with patient clinicopathological parameters, disease-free survival (DFS) and overall survival(OS). Both univariate and multivariate analyses were performed to identify the clinicopathological parameters associated with DFS and OS. Elevated preoperative plasma fibrinogen levels were directly associated with age of diagnose (≤47 vs. >47, p<0.001), menopause (yes vs. no, p<0.001), tumor size (T1&T2 vs.T3&T4, p = 0.033), tumor stage (Ⅰvs.Ⅱvs.Ⅲ, p = 0.034) and lymph node involvement (N = 0 vs. 1≤N≤3 vs. N≥4, p<0.001), but not with histological grade, molecular type and other Immunohistochemical parameters(ER, PR, HER2 and Ki-67). In a univariate survival analysis, tumor stage, tumor size, lymph node involvement (p<0.001/ p<0.001)and plasma fibrinogen (p<0.001/ p<0.001) levels were associated with disease-free and overall survival, but just lymph nodes involvement (p<0.001, hazard ratio [HR] = 2.9, 95% confidence interval [CI] = 1.6–5.3/ p = 0.006, HR = 3.2, 95% CI = 1.4–7.3) and plasma fibrinogen levels (p = 0.006, HR = 3.4, 95% CI = 1.4–8.3/ p = 0.002, HR = 10.1, 95% CI = 2.3–44.6) were associated with disease-free and overall survival in a multivariate survival analysis, respectively. This study demonstrates that elevated preoperative plasma fibrinogen levels are associated with breast cancer progression and are independently associated with a poor prognosis in patients with operable breast cancer.

20 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYanrong Lv
Yanrong Lv
SSShanshan Song
Shanshan Song
KZKai Zhang
Kai Zhang
HGHaidong Gao
Haidong Gao
RMRong Ma
Rong Ma
A number of studies have shown that apoptosis resistance can be observed in multiple human tumors; however the detailed mechanism remains unclear. In the present study, we demonstrated that the abnormal overexpression of the C terminus of Hsc70-interacting protein (CHIP) induced apoptosis resistance by regulating the AKT/FoxO/Bim signaling pathway in the breast cancer cell MCF7 and the human non-tumorigenic cell MCF10A. We found that CHIP overexpression in MCF7 and MCF10A cells activated AKT and inhibited the Forkhead box O (FoxO) transcription factors FoxO1, FoxO3, and FoxO4, thereby inhibiting transcription of the target genes bim and pten. Inhibition of PI3K by a chemical reagent revealed that these events may be critical for CHIP-induced apoptosis resistance. We also determined that inhibition of FoxO3 by CHIP led to the decrease in PTEN and further activated the AKT survival pathway. We corroborated our findings in breast cancer tissues. In general, the CHIP-modulated AKT/FoxO/Bim signaling pathway was shown to induce apoptosis resistance by decreasing the protein level of the tumor suppressor PTEN in both transcriptional and post-translational regulations.